Page last updated: 2024-10-24

chlorambucil and Incontinentia Pigmenti Achromians

chlorambucil has been researched along with Incontinentia Pigmenti Achromians in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rose, MS1
Levantine, A1
Almeyda, J1

Reviews

1 review available for chlorambucil and Incontinentia Pigmenti Achromians

ArticleYear
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
    The British journal of dermatology, 1974, Volume: 90, Issue:2

    Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlor

1974

Other Studies

1 other study available for chlorambucil and Incontinentia Pigmenti Achromians

ArticleYear
Busulphan toxicity syndrome caused by chlorambucil.
    British medical journal, 1975, Apr-19, Volume: 2, Issue:5963

    Topics: Aged; Busulfan; Chlorambucil; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Pigmentation Di

1975